Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of ibuprofen + paracetamol for primary dysmenorrhoea
2018-000138-37Phase 3Completed
- Sponsor
- Farmalíder
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ibuprofen and acetaminophen in primary dysmenorrhea (PD) (4 arms), sponsored by Farmalíder. Primary endpoint: Pain intensity difference at 6 hours. Started Feb 2018; status: completed.
02
Drugs
ibuprofenacetaminophen
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on 2018-000138-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-000138-37.